Cargando…

The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study

OBJECTIVES: Data on long‐term HIV‐free survival in breastfeeding, HIV‐exposed infants (HEIs) are limited. The National Evaluation of Malawi’s Prevention of Mother‐to‐Child Transmission (PMTCT) Program (NEMAPP), conducted between 2014 and 2018, evaluated mother‐to‐child transmission (MTCT) and infant...

Descripción completa

Detalles Bibliográficos
Autores principales: van Lettow, Monique, Tippett Barr, Beth A., van Oosterhout, Joep J., Schouten, Erik, Jahn, Andreas, Kalua, Thokozani, Auld, Andrew, Nyirenda, Rose, Wadonda, Nellie, Kim, Evelyn, Landes, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303195/
https://www.ncbi.nlm.nih.gov/pubmed/34970836
http://dx.doi.org/10.1111/hiv.13209
_version_ 1784751802541932544
author van Lettow, Monique
Tippett Barr, Beth A.
van Oosterhout, Joep J.
Schouten, Erik
Jahn, Andreas
Kalua, Thokozani
Auld, Andrew
Nyirenda, Rose
Wadonda, Nellie
Kim, Evelyn
Landes, Megan
author_facet van Lettow, Monique
Tippett Barr, Beth A.
van Oosterhout, Joep J.
Schouten, Erik
Jahn, Andreas
Kalua, Thokozani
Auld, Andrew
Nyirenda, Rose
Wadonda, Nellie
Kim, Evelyn
Landes, Megan
author_sort van Lettow, Monique
collection PubMed
description OBJECTIVES: Data on long‐term HIV‐free survival in breastfeeding, HIV‐exposed infants (HEIs) are limited. The National Evaluation of Malawi’s Prevention of Mother‐to‐Child Transmission (PMTCT) Program (NEMAPP), conducted between 2014 and 2018, evaluated mother‐to‐child transmission (MTCT) and infant outcomes up to 24 months postpartum. METHODS: We enrolled a nationally representative cohort of HEIs at 54 health facilities across four regional strata in Malawi and used multivariable Cox regression analysis to investigate the risk of adverse outcomes (HIV transmission, infant death and loss to follow‐up) to 24 months postpartum. Models, controlling for survey design, were fitted for the total cohort (n = 3462) and for a subcohort that received maternal viral load (VL) monitoring (n = 1282). RESULTS: By 24 months, in 3462 HEIs, weighted cumulative MTCT was 4.9% [95% confidence interval (CI) 3.7–6.4%], 1.3% (95% CI 0.8–2.2%) of HEIs had died, 26.2% (95% CI 24.0–28.6%) had been lost to follow‐up and 67.5% (95% CI 65.0–70.0%) were alive and HIV‐free. Primiparity [weighted adjusted hazard ratio (aHR) 1.6; 95% CI 1.1–2.2; parity 2–3: weighted aHR 1.5; 95% CI 1.2–1.9], the mother not disclosing her HIV status to her partner (no disclosure: weighted aHR 1.3; 95% CI 1.1–1.6; no partner: weighted aHR 0.7; 95% CI 0.5–0.9), unknown maternal ART start (weighted aHR 2.0; 95% CI 1.0–3.9) and poor adherence (missed ≥ 2 days of ART in the last month: weighted aHR 1.7; 95% CI 1.2–2.2; not on ART: weighted aHR 1.7; 95% CI 1.0–2.7) were associated with adverse outcomes by 24 months. In the subcohort analysis, risk of HIV transmission or infant death was higher among HEIs whose mothers started ART post‐conception (during pregnancy: weighted aHR 3.2; 95% CI 1.3–7.7; postpartum: weighted aHR 12.4; 95% CI 1.5–99.6) or when maternal viral load at enrolment was > 1000 HIV‐1 RNA copies/mL (weighted aHR 15.7; 95% CI 7.8–31.3). CONCLUSIONS: Infant positivity and infant mortality at 24 months were low for a breastfeeding population. Starting ART pre‐conception had the greatest impact on HIV‐free survival in HEIs. Further population‐level reduction in MTCT may require additional intervention during breastfeeding for women new to PMTCT programmes. Pre‐partum diagnosis and linkage to ART, followed by continuous engagement in care during breastfeeding can further reduce MTCT but are challenging to implement.
format Online
Article
Text
id pubmed-9303195
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93031952022-07-22 The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study van Lettow, Monique Tippett Barr, Beth A. van Oosterhout, Joep J. Schouten, Erik Jahn, Andreas Kalua, Thokozani Auld, Andrew Nyirenda, Rose Wadonda, Nellie Kim, Evelyn Landes, Megan HIV Med Original Research OBJECTIVES: Data on long‐term HIV‐free survival in breastfeeding, HIV‐exposed infants (HEIs) are limited. The National Evaluation of Malawi’s Prevention of Mother‐to‐Child Transmission (PMTCT) Program (NEMAPP), conducted between 2014 and 2018, evaluated mother‐to‐child transmission (MTCT) and infant outcomes up to 24 months postpartum. METHODS: We enrolled a nationally representative cohort of HEIs at 54 health facilities across four regional strata in Malawi and used multivariable Cox regression analysis to investigate the risk of adverse outcomes (HIV transmission, infant death and loss to follow‐up) to 24 months postpartum. Models, controlling for survey design, were fitted for the total cohort (n = 3462) and for a subcohort that received maternal viral load (VL) monitoring (n = 1282). RESULTS: By 24 months, in 3462 HEIs, weighted cumulative MTCT was 4.9% [95% confidence interval (CI) 3.7–6.4%], 1.3% (95% CI 0.8–2.2%) of HEIs had died, 26.2% (95% CI 24.0–28.6%) had been lost to follow‐up and 67.5% (95% CI 65.0–70.0%) were alive and HIV‐free. Primiparity [weighted adjusted hazard ratio (aHR) 1.6; 95% CI 1.1–2.2; parity 2–3: weighted aHR 1.5; 95% CI 1.2–1.9], the mother not disclosing her HIV status to her partner (no disclosure: weighted aHR 1.3; 95% CI 1.1–1.6; no partner: weighted aHR 0.7; 95% CI 0.5–0.9), unknown maternal ART start (weighted aHR 2.0; 95% CI 1.0–3.9) and poor adherence (missed ≥ 2 days of ART in the last month: weighted aHR 1.7; 95% CI 1.2–2.2; not on ART: weighted aHR 1.7; 95% CI 1.0–2.7) were associated with adverse outcomes by 24 months. In the subcohort analysis, risk of HIV transmission or infant death was higher among HEIs whose mothers started ART post‐conception (during pregnancy: weighted aHR 3.2; 95% CI 1.3–7.7; postpartum: weighted aHR 12.4; 95% CI 1.5–99.6) or when maternal viral load at enrolment was > 1000 HIV‐1 RNA copies/mL (weighted aHR 15.7; 95% CI 7.8–31.3). CONCLUSIONS: Infant positivity and infant mortality at 24 months were low for a breastfeeding population. Starting ART pre‐conception had the greatest impact on HIV‐free survival in HEIs. Further population‐level reduction in MTCT may require additional intervention during breastfeeding for women new to PMTCT programmes. Pre‐partum diagnosis and linkage to ART, followed by continuous engagement in care during breastfeeding can further reduce MTCT but are challenging to implement. John Wiley and Sons Inc. 2021-12-30 2022-07 /pmc/articles/PMC9303195/ /pubmed/34970836 http://dx.doi.org/10.1111/hiv.13209 Text en © 2021 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
van Lettow, Monique
Tippett Barr, Beth A.
van Oosterhout, Joep J.
Schouten, Erik
Jahn, Andreas
Kalua, Thokozani
Auld, Andrew
Nyirenda, Rose
Wadonda, Nellie
Kim, Evelyn
Landes, Megan
The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study
title The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study
title_full The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study
title_fullStr The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study
title_full_unstemmed The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study
title_short The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study
title_sort national evaluation of malawi’s pmtct program (nemapp) study: 24‐month hiv‐exposed infant outcomes from a prospective cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303195/
https://www.ncbi.nlm.nih.gov/pubmed/34970836
http://dx.doi.org/10.1111/hiv.13209
work_keys_str_mv AT vanlettowmonique thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT tippettbarrbetha thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT vanoosterhoutjoepj thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT schoutenerik thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT jahnandreas thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT kaluathokozani thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT auldandrew thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT nyirendarose thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT wadondanellie thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT kimevelyn thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT landesmegan thenationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT vanlettowmonique nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT tippettbarrbetha nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT vanoosterhoutjoepj nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT schoutenerik nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT jahnandreas nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT kaluathokozani nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT auldandrew nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT nyirendarose nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT wadondanellie nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT kimevelyn nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy
AT landesmegan nationalevaluationofmalawispmtctprogramnemappstudy24monthhivexposedinfantoutcomesfromaprospectivecohortstudy